 She has also pursued training in Internal Medicine and Hematology at McMaster, University of Toronto, and Harvard University.Starting in 1989, Olivieri was part of a group evaluating the use of a drug, deferiprone, in treating persons with the blood disorder thalassaemia.Starting from 1985, this work included a clinical trial partly funded by Apotex.